Works matching IS 13406868 AND DT 2023 AND VI 30 AND IP 3

Results: 14

Severity and risk factors of interval breast cancer in Queensland, Australia: a population-based study.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 466, doi. 10.1007/s12282-023-01439-4

By:

Kou, Kou;
Cameron, Jessica;
Youl, Philippa;
Pyke, Chris;
Chambers, Suzanne;
Dunn, Jeff;
Aitken, Joanne F.;
Baade, Peter D.

Publication type:

Article

Programmed death ligand 1-positive immune cells in primary tumor or metastatic axillary lymph nodes can predict prognosis of triple-negative breast cancer even when present at < 1% in the tumor region.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 497, doi. 10.1007/s12282-023-01442-9

By:

Tomioka, Nobumoto;
Hatanaka, Kanako C.;
Okuyama, Dai;
Watanabe, Ken-ichi;
Yamamoto, Mitsugu;
Maeda, Hideki;
Tachikawa, Hanae;
Kuwahara, Sayuri;
Shimizu, Ai;
Suzuki, Hiroaki;
Hatanaka, Yutaka;
Takahashi, Masato

Publication type:

Article

Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within breast cancer subtypes and stages among older women: a SEER-Medicare analysis.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 489, doi. 10.1007/s12282-023-01441-w

By:

Zhang, Hanxi;
Barner, Jamie C.;
Moczygemba, Leticia R.;
Rascati, Karen L.;
Park, Chanhyun;
Kodali, Dhatri

Publication type:

Article

Construction of a prognostic risk assessment model for HER2 + breast cancer based on autophagy-related genes.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 478, doi. 10.1007/s12282-023-01440-x

By:

Wang, Fan;
Fang, Linghui;
Fu, Bifei;
Fan, Chen

Publication type:

Article

Phase 1 study of oral selective estrogen receptor degrader (SERD) amcenestrant (SAR439859), in Japanese women with ER-positive and HER2-negative advanced breast cancer (AMEERA-2).

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 506, doi. 10.1007/s12282-023-01443-8

By:

Tamura, Kenji;
Mukohara, Toru;
Yonemori, Kan;
Kawabata, Yumiko;
Nicolas, Xavier;
Tanaka, Tomoyuki;
Iwata, Hiroji

Publication type:

Article

Dynamic network biomarker to determine the critical point of breast cancer stage progression.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 453, doi. 10.1007/s12282-023-01438-5

By:

Jiang, Fa;
Yang, Lifeng;
Jiao, Xiong

Publication type:

Article

ER–/PR+ breast cancer is controlled more effectively with an inflammatory inhibitor than hormonal inhibitor.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 436, doi. 10.1007/s12282-023-01437-6

By:

Song, Christine;
Kendi, Ayse Tuba;
Shim, Ji Yeon;
Jung, Dawa;
Kang, Pil Soo;
Lowe, Val J.;
Lee, SeungBaek

Publication type:

Article

Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1).

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 412, doi. 10.1007/s12282-023-01436-7

By:

Imoto, Shigeru;
Wang, Kun;
Bi, Xi-wen;
Liu, Guangyu;
Im, Young-Hyuck;
Im, Seock-Ah;
Sim, Sung Hoon;
Ueno, Takayuki;
Futamura, Manabu;
Toi, Masakazu;
Fujiwara, Yasuhiro;
Ahn, Sung Gwe;
Lee, Jeong Eon;
Park, Yeon Hee;
Takao, Shintaro;
Oba, Mari Saito;
Kitagawa, Yuko;
Nishiyama, Masahiko

Publication type:

Article

Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 424, doi. 10.1007/s12282-023-01435-8

By:

Qing, Xin;
Yuan, Chunlei;
Wang, Ke

Publication type:

Article

Construction and characterization of a cuproptosis- and immune checkpoint-based LncRNAs signature for breast cancer risk stratification.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 393, doi. 10.1007/s12282-023-01434-9

By:

Li, Yan;
Na, Feiyang;
Pei, Jianying

Publication type:

Article

Identification of prognostic genes signature and construction of ceRNA network in pirarubicin treatment of triple-negative breast cancer.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 379, doi. 10.1007/s12282-023-01433-w

By:

Ma, Jiulong;
Wang, Fengjun;
Chen, Chen;
Ji, Jiahua;
Huang, Peng;
Wei, Dexian;
Zhang, Yang;
Ren, Liqun

Publication type:

Article

HER2-positive invasive lobular carcinoma: a rare breast cancer which may not necessarily require anti-HER2 therapy. A population-based study.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 343, doi. 10.1007/s12282-022-01432-3

By:

kada Mohammed, Samia;
Billa, Oumar;
Ladoire, Sylvain;
Jankowski, Clementine;
Desmoulins, Isabelle;
Poillot, Marie-Laure;
Coutant, Charles;
Beltjens, Françoise;
Dabakuyo, Sandrine;
Arnould, Laurent

Publication type:

Article

HER2-low-positive and response to NACT and prognosis in HER2-negative non-metastatic BC.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 364, doi. 10.1007/s12282-022-01431-4

By:

Li, Jing-Jing;
Yu, Yue;
Ge, Jie

Publication type:

Article

Prognostic effect of subsequent childbirth after the diagnosis of breast cancer using propensity score matching analysis.

Published in:

Breast Cancer (13406868), 2023, v. 30, n. 3, p. 354, doi. 10.1007/s12282-022-01429-y

By:

Ochi, Tomohiro;
Yoshida, Atsushi;
Takahashi, Osamu;
Kajiura, Yuka;
Takei, Junko;
Hayashi, Naoki;
Takei, Hiroyuki;
Yamauchi, Hideko

Publication type:

Article